Intrinsiqq
My Beat AB logo

My Beat AB Quality Score

MYBEAT.XSTO

⊜ Compare
Quality30

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Revenue Growth
100/100
31.6%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
797.2%

Heavy dilution above 5%

Margin Trend
100/100
+5.0pp

Expanded 3+pp, strong improvement

Capital Structure
0/100
$11M

Positive debt with no FCF to service it

2021
$68423
$3.00M
2022
$115000
$4.00M
2023
$940887
$7.00M
2025
$411000
$11.0M
CashDebt
Return on Capital
0/100
-36.5%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MYBEAT.XSTO

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.